Although statistically significant differences in TGFB1 gene expression were found in patients with SSc-ILD compared to those with SSc-nonILD, ROC analysis did not confirm that TGFB1 had sufficient capacity to differentiate between these two groups of patients (Figure 3B, Table S1). This evidence concerns the gene TGFB1 and systemic sclerosis.